Rates of Opioid Misuse Amongst Patients Receiving Pain Management for Sickle Cell Disease in An Urban Setting

被引:0
作者
Ahmed, Nadia [1 ]
Okany, Nkemjika [1 ]
Singh, Divita [2 ]
Rungkitwattanaku, Dhakrit [1 ]
Weaver, Salome B. [1 ]
机构
[1] Howard Univ, Coll Pharm, Clin Adm & Pharm Sci, Washington, DC 20059 USA
[2] Temple Univ, Sch Pharm, Philadelphia, PA 19122 USA
关键词
sickle cell disease; opioid misuse; pain management; CRISES; FREQUENCY; HOSPITALIZATION; HYDROXYUREA; CANNABIS; ANEMIA; ADULTS; TRIAL;
D O I
10.1177/08971900221128335
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and Objective: Sickle Cell Disease (SCD) is known to cause acute severe pain episodes known as vaso-occlusive crisis (VOC) mainly treated with opioid analgesics. Since the opioid epidemic there is an interest in determining the opioid misuse potential in these patients. Therefore, the primary objective of this study is to determine the rates of opioid misuse among patients with SCD by assessing the rate of unexpected drug screening results in a sickle cell disease clinic. Methods: This was a retrospective chart review study conducted at the outpatient sickle cell disease clinic. The primary independent variables were the prescribed opioid medications while the primary dependent variable was the collected opioid metabolite. Descriptive statistics, linear regression and multivariate logistic regression analysis were conducted using SPSS version 24. Results: A total of 100 participants were recruited from July 1, 2018, to June 30, 2020 with 71 included in the analysis. The total mean of morphine milligram equivalents (MME) for all participants was 71.1 +/- 104.9 with 71% of participants having a daily calculated MME of <90MME. The odds of misusing an opioid were 6.72 times higher (P<.02) if a participant used marijuana compared to a participant who didn't. In addition, the odds of misusing an opioid were 2.47 times higher (P<.04) if the patient was prescribed an opioid daily dose greater than 90 MME as opposed to a daily dose less than 90 MME. Conclusion: Participants who consumed greater than 90 MME's per day and utilized marijuana were more likely to misuse opioids.
引用
收藏
页码:104 / 109
页数:6
相关论文
共 50 条
  • [21] Pain management in sickle cell disease
    Rasche, T.
    Emmert, D.
    Seidel, H.
    Sellin, J.
    Conrad, R.
    Muecke, M.
    SCHMERZ, 2020, 34 (03): : 285 - 295
  • [22] Increased Clearance of Morphine in Sickle Cell Disease: Implications for Pain Management
    Darbari, Deepika S.
    Neely, Michael
    van den Anker, John
    Rana, Sohail
    JOURNAL OF PAIN, 2011, 12 (05) : 531 - 538
  • [23] Management of severe chronic pain with methadone in pediatric patients with sickle cell disease
    LeBlanc, Zachary
    Vance, Chris
    Payne, Jason
    Zhang, Jie
    Hilliard, Lee
    Lebensburger, Jeffrey D.
    Howard, Thomas H.
    PEDIATRIC BLOOD & CANCER, 2018, 65 (08)
  • [24] Patient and Family Opioid Decision-Making for Pain Management in Sickle Cell Disease: A Qualitative Study
    Phillips, Shannon
    Schlenz, Alyssa M.
    D'Alton, Shannon
    Johnson, Mary
    Kanter, Julie
    JOURNAL OF PAIN, 2023, 24 (07) : 1240 - 1250
  • [25] Pediatric Sickle Cell Disease Patients on Hydroxyurea Have Higher Rates of Surgical Splenectomy
    Menchaca, Alicia D.
    Style, Candace C.
    Villella, Anthony D.
    Burdjalov, Maria
    Beyene, Tariku J.
    Minneci, Peter C.
    Olutoye, Oluyinka O.
    JOURNAL OF SURGICAL RESEARCH, 2023, 283 : 798 - 805
  • [26] Acupuncture for pain management in children with sickle cell disease
    Mahmood, Laila A.
    Reece-Stremtan, Sarah
    Idiokitas, Risi
    Martin, Brenda
    Margulies, Stefanie
    Hardy, Steven J.
    Bost, James E.
    Darbari, Deepika S.
    COMPLEMENTARY THERAPIES IN MEDICINE, 2020, 49
  • [27] Pain management in children and adolescents with sickle cell disease
    Jerrell, Jeanette M.
    Tripathi, Avnish
    Stallworth, James R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (01) : 82 - 84
  • [28] Psychosocial Treatments in Pain Management of Sickle Cell Disease
    Edwards, LeKisha Y.
    Edwards, Christopher L.
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2010, 102 (11) : 1084 - 1094
  • [29] Pediatric residents' perceived barriers to opioid use in sickle cell disease pain management
    Fearon, Amber
    Marsh, Anne
    Kim, Jennifer
    Treadwell, Marsha
    PEDIATRIC BLOOD & CANCER, 2019, 66 (02)
  • [30] Outpatient management of sickle cell pain with chronic opioid pharmacotherapy
    Shaiova, L
    Wallenstein, D
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2004, 96 (07) : 984 - 986